Breathing and Bones Initiative
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project will examine the current diagnosis and treatment of bone health in patients with obstructive airway disease. Patients will be referred to The Osteoporosis Centre of BC (OCBC) by their respirologist to be assessed for osteoporosis including Dual Energy Xray Absorptiometry (DXA) scan. Previous chest xrays and will be accessed and examined for vertebral fractures, diagnostic of osteoporosis. The lung and bone data will be entered into a database. This will allow us to explore the relationship of lung disease parameters to osteoporosis predictors, eventually determining a respirology patient population who are at high risk of fracture. Longitudinal evaluation of bone health and its relationship to respiratory parameters over time will be explored by follow-up evaluations at 12 and 24 months.
| Condition |
|---|
|
Osteoporosis Obstructive Lung Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study |
- To determine the prevalence of osteoporosis in the respiratory disease population, as determined by bone density and fragility fracture. [ Designated as safety issue: No ]
- To associate osteoporosis with severity of pulmonary disease in respirology disease patients. [ Designated as safety issue: No ]
| Estimated Enrollment: | 120 |
| Study Start Date: | July 2010 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
Show Detailed Description Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients will be drawn from specified respirology clinics: The Lung Centre (VCH) and The Pacific Lung Centre (PHC)
Inclusion Criteria:
- men and women over 65 years of age with obstructive airway disease being seen by a respirologist in their clinical practices
Exclusion Criteria:
- less than 65 years of age
- patient has had bone density scan within the last 2 years
- patient is currently being treated for osteoporosis (alendronate, risedronate, zoledronate, etidronate, clodronate, raloxifene, calcitonin, estrogen)
Contacts and Locations| Contact: Ashley Smith | 604-789-7726 | ashley.smith@vch.ca |
| Canada, British Columbia | |
| The Osteoporosis Centre of BC (Bone Consultaton and Bone Mineral Density) | Recruiting |
| Vancouver, British Columbia, Canada, V5H 3X8 | |
| The Lung Centre, Vancouver Coastal Health, 7th Floor 2775 Laurel Street | Recruiting |
| Vancouver, British Columbia, Canada, V5Z 1M9 | |
| The Pacific Lung Centre, Providence Health Care | Recruiting |
| Vancouver, British Columbia, Canada, V6Z 1Y6 | |
| Principal Investigator: | Mark FitzGerald, MD | University of British Columbia |
More Information
Publications:
| Responsible Party: | University of British Columbia |
| ClinicalTrials.gov Identifier: | NCT01161680 History of Changes |
| Other Study ID Numbers: | H10-00983 |
| Study First Received: | June 22, 2010 |
| Last Updated: | November 21, 2011 |
| Health Authority: | Canada: Health Canada |
Keywords provided by University of British Columbia:
|
Cross sectional and Longitudinal Observational study |
Additional relevant MeSH terms:
|
Lung Diseases Pulmonary Disease, Chronic Obstructive Osteoporosis Lung Diseases, Obstructive |
Respiratory Tract Diseases Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on June 13, 2013